Theta Burst Stimulation in fibromyalgia
- Conditions
- FibromyalgiaMusculoskeletal - Other muscular and skeletal disordersNeurological - Other neurological disorders
- Registration Number
- ACTRN12617000487314
- Lead Sponsor
- Dr Bernadette Fitzgibbon
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria: patients will be included if they:
- have a current diagnosis of fibromyalgia
- aged between 18 and 75 years
- have had no increase or initiation of new medication therapy in the four weeks prior to study screen
Exclusion Criteria: Participants who:
- Patients who have an unstable medical condition, neurological disorder or any history of seizure disorder or are currently pregnant or lactating
- The presence of metal anywhere in the head, except the mouth, which may interfere with the magnetic field
- Have a current DSM-V diagnosis of Substance Abuse or Dependence disorder, or another psychiatric condition. This excludes depression, PTSD or anxiety unless they are the primary disorder (i.e. fibromyalgia is not the primary disorder).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in severity and impact of pain as measured by the Brief Pain Inventory (Short-form).[Baseline versus 4 weeks versus 8 weeks];Multifaceted Fatigue Inventory[Baseline versus 4 weeks versus 8 weeks]
- Secondary Outcome Measures
Name Time Method